TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Sickle Cell Site Mobilisation #4

Administrative healthcare services
Services furnished by specialist organisations
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Genomics England Limited: "Sickle Cell Site Mobilisation #4". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityGenomics England LimitedScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Genomics England Limited
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Genomics England Limited. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityGenomics England Limited
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published1 May 2024, 16:07 BST
Last source update1 May 2024, 16:07 BST
Recurring procurementNot published
ClassificationAdministrative healthcare services, Services furnished by specialist organisations
Delivery area
UK
OCIDocds-h6vhtk-0456a3
What is being bought
Consenting and re-consenting of patients with sickle cell disorder into the NIHR Bioresource’s Improving Black Health Outcomes (IBHO) project.
What changed
From the official release history
  1. Status changed to complete
    1 May 2024, 16:07 BST
  2. Official notice release published
    1 May 2024, 16:07 BST
  3. Buyer information updated
    1 May 2024, 16:07 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Introducing patients to the study ahead of annual reviews and routine appointments in specialist sickle cell consultant clinics. Sharing the Patient Information Sheet (PIS) with patients and answering any questions. Coordinating sample collection with annual reviews and routine phlebotomy appointments. Processing consent documentation. Following up with patients to ensure they receive Diverse Data’s questionnaire and ensuring other provisions are made for those who are not able to complete the questionnaire online. Support provided to participants to complete the questionnaire when required.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    1 May 2024, 16:07 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 1 May 2024, 00:00 BST · £138,408
Commercial outcome and competition
Awards
University College London Hospitals
Not published · Not published · active
Contracts
Sickle Cell Site Mobilisation #4
£138,408 · signed 1 May 2024, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Genomics England Limited

Contracting authority GB-FTS-112668
View buyer profile
  • Genomics England Limited
    buyer

    London, UK
    +44 2078825030
  • The High Court
    reviewBody

    London
  • University College London Hospitals
    supplier

    London, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Contracting Authority (i) has a legal personality; (ii) is mainly funded by the Department of Health and Social Care; and (iii) has been established for the specific purpose of meeting needs in the general interest, and does not have an industrial or commercial character and therefore meets the definition of a "body governed by public law" under the Public Contracts Regulations 2015 ("PCR"). The PCR covers "public contracts" which means contracts for pecuniary interest which have as their object the execution of works, the supply of products or the provision of services. The Contract is a services contract under PCR, therefore, caught by the PCR and therefore bound to follow public procurement rules. Regulation 32(2)(b)(ii) PCR describes the single operator exclusion and is the premise for this award without prior publication. This specific exclusion relates to a requirement to access patients already registered with a specific NHS Hospital Trust. As such the services in question cannot be obtained by any other economic operator. The Contracting Authority will enter into a contract with Imperial College London following the conclusion of a minimum 10 day standstill period from the date of issue of this notice. The 10 day standstill period will end on 11/05/20224 at 23.59 BST, enabling a contract to be signed on 13/05/2024.